MedPath

CancerCOVID - Allocating resources for cancer care in times of the Sars-CoV-2 outbreak. Evidence and ethical implications

Conditions
Colorectal cancer, pancreatic cancercoronary heart disease, diabetes mellitus, multiple sclerosis
Registration Number
DRKS00026043
Lead Sponsor
Institut für Geschichte und Ethik der Medizin, Martin-Luther-Universität Halle-Wittenberg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
272
Inclusion Criteria

patients: presence of gastrointestinal cancer

Exclusion Criteria

lack of knowledge of German language, lack of capacity to give consent, Patients: veto of the treatment team

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Aim: Assessment of ethical and psychosocial challenges in cancer care via semi-structured interviews with stakeholders (oncologists, nurses, patients) between January and July 2021. Assessment of psychosocial burden of oncologists, nurses and patients between February and July 2021 via questionnaires.<br>patients: Mini-SCL, EORTC QLQ-C30, NCCN Distress Thermometer, FACT-19<br>oncologists: PHQ-9, PHQ-15, GAD-7, Maslach Burnout Inventory, Moral Distress Thermometer, FACT-19, sociodemographic questionnaire<br>nurses: PHQ-9, PHQ-15, GAD-7, Maslach Burnout Inventory, Moral Distress Thermometer, FACT-19, BERNCA, sociodemographic questionnaire
Secondary Outcome Measures
NameTimeMethod
does not apply
© Copyright 2025. All Rights Reserved by MedPath